Oruka Therapeutics Inc Share Price

NASDAQ: ORKA

Small Cap

$14.87

-0.39

(-2.56%)

as on September 17, 2025 at 1:29 am IST

$₹

Oruka Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$14.67
Day's Price Range
$15.55
$14.87
1.34%
Downside
4.57%
Upside
52 Week's Low
52 Week's High
$5.49
52-Week Price Range
$31.13
$14.87
63.11%
Downside
109.35%
Upside

Oruka Therapeutics Inc share price movements today

Previous Close: $15.26
Open: $15.19
Volume: 306.8K
Day's Low - High: $14.67 - $15.55
52 Week Low - High: $5.49 - $31.13

Oruka Therapeutics Inc Historical Returns

1 Month Return: -0.72 %
3 Month Return: + 22.77 %
1 Year Return: -41.08 %
3 Year Return: 0 %
5 Year Return: 0 %

Oruka Therapeutics Inc Stock Fundamentals & Key Indicators

Check Oruka Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$576.7M

EPS (TTM)

-1.98

Dividend Yield

0.00%

PE Ratio (TTM)

P/B Ratio

PEG Ratio

Return On Equity TTM

6643000.00%

Oruka Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oruka Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Oruka Therapeutics Inc	NA	$576.7M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Oruka Therapeutics Inc Stock including INR - Dollar returns

The Oruka Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Oruka Therapeutics Inc investment value today

Current value as on today

₹62,281

Returns

₹37,719

(-37.72%)

Returns from Oruka Therapeutics Inc Stock

₹42,587 (-42.59%)

Dollar Returns*

₹4,867 (+4.87%)

Oruka Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Oruka Therapeutics Inc Stock has increased by 33% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:33% versus previous 30 day period

Oruka Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-
Gross Profit	0	0	0	0	0
Operating Income	-2	-25	-29	-25	-28
EBITDA	-1	-22	-28	-20	-24
Interest Expense	0	0	0	-	-
Depreciation	-	-	-	0	0
Income Before Tax	-2	-27	-28	-20	-24
Income Tax Expense	-	-	-	-	-
Net Income	-2	-27	-28	-20	-24
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%

Oruka Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD


Total Revenue
Gross Profit
Operating Income
EBITDA
Interest Expense
Depreciation
Income Before Tax
Income Tax Expense
Net Income
Net Profit Margin

Oruka Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Sep 2021	Dec 2021	Mar 2022	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-5	-3	-7	-2	-28	-25	-20	-24
Operating Cash Flow	-4	-4	-4	0	-2	-34	-18	-20	-23
Investing Cash Flow	0	0	0	-	-	0	-329	42	4
Financing Cash Flow	-	-	-	27	0	450	0	-	0
Change in Cash	-4	-4	-4	27	-2	377	-349	21	-18

Oruka Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2024
Net Income	-11	-16	-18	-7	-5	-9	-19	-9	-83
Operating Cash Flow	-10	-14	-17	-8	-4	-7	-18	-10	-57
Investing Cash Flow	0	-16	12	3	0	0	0	0	-330
Financing Cash Flow	33	-	5	3	6	48	23	-	449
Change in Cash	23	-31	1	-2	1	40	4	-10	24

Insights on Oruka Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 162.8%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 70.6% return, outperforming this stock by 111.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, ORKA stock has moved down by -4.9%

About Oruka Therapeutics Inc

Oruka Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing novel monoclonal antibody therapeutics for psoriasis (PsO) and other inflammatory and immunology (I&I) indications. Its lead program, ORKA-001, is designed to target the p19 subunit of interleukin-23 (IL-23p19) for the treatment of PsO. Its co-lead program, ORKA-002, is designed to target interleukin-17A and interleukin-17F (IL-17A/F) for the treatment of PsO, psoriatic arthritis (PsA), and other conditions. ORKA-001 is an extended half-life monoclonal antibody (mAb) designed to target IL-23p19. IL-23 is a pro-inflammatory cytokine that plays a critical role in the proliferation and development of T helper 17 (Th17) cells, which are the primary drivers of several autoimmune and inflammatory disorders, including PsO. IL-23 is composed of two subunits: a p40 subunit and a p19 subunit. ORKA-002 is an extended half-life mAb designed to target IL-17A and IL-17F (IL-17A/F).

Organisation	Oruka Therapeutics Inc
Headquarters	855 Oak Grove Avenue, Menlo Park, CA, United States, 94025
CEO	Dr. Lawrence Otto Klein Ph.D.
E-voting on shares	Click here to vote

Key Management of Oruka Therapeutics Inc

Name	Title
Dr. Joe Senn Ph.D.	Senior Vice President of Nonclinical Research & Development
Dr. Lawrence Otto Klein Ph.D.	President, CEO & Director
Dr. Joana Goncalves M.D.	Chief Medical Officer
Mr. Alan Lada	Vice President of Investor Relations
Mr. Christopher Finch	Vice President of Corporate Development & Strategy
Dr. Rajiv Panwar	VP and Head of Chemistry, Manufacturing & Controls
Mr. Paul T. Quinlan	General Counsel & Secretary
Mr. Arjun Agarwal CPA	Senior VP of Finance & Treasurer
Ms. Laura Sandler	Chief Operating Officer

FAQs

What is Oruka Therapeutics Inc share price today?

Oruka Therapeutics Inc share price today is $14.87 as on September 17, 2025 at 1:29 am IST at the close of the market. Oruka Therapeutics Inc share today touched a day high of $15.55 and a low of $14.67.

What is the 52 week high and 52 week low for Oruka Therapeutics Inc share?

Oruka Therapeutics Inc share touched a 52 week high of $31.13 on October 21, 2024 and a 52 week low of $5.49 on April 9, 2025. Oruka Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $14.87,which is 52.23% down from its 52 week high and 171.10% up from its 52 week low.

What is Oruka Therapeutics Inc's market capitalisation today?

Oruka Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Oruka Therapeutics Inc Stock (ORKA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oruka Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Oruka Therapeutics Inc Shares that will get you 0.1009 shares as per Oruka Therapeutics Inc share price of $14.87 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Oruka Therapeutics Inc Stock (ORKA) from India?

Indian investors can start investing in Oruka Therapeutics Inc (ORKA) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 2:40 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Oruka Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 2:40 am IST). Based on Oruka Therapeutics Inc share’s latest price of $14.87 as on September 17, 2025 at 1:29 am IST, you will get 0.6725 shares of Oruka Therapeutics Inc. Learn more about fractional shares .